Clinical Research Coordinator
Maya was lead coordinator on three landmark studies investigating Pfizer’s antiviral treatment for COVID-19. Thanks to her hard work and dedication to these trials, MBR was one of the highest enrolling sites in the country and significantly contributed to the record time in which this life-saving medication was approved.
Maya’s experience includes studies investigating treatments for Asthma, COPD, Diabetes, Hypertension, Alzheimers, and COVID-19. She also has experience with studies investigating vaccines for RSV and Influenza.